Docusign (NASDAQ:DOCU) Posts Earnings Results, Beats Expectations By $0.06 EPS

Docusign (NASDAQ:DOCU) posted its earnings results on Tuesday. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.06, FiscalAI reports. The company had revenue of $836.86 million for the quarter, compared to analyst estimates of $828.23 million. Docusign had a net margin of 9.57% and a return on equity of 15.02%. Docusign’s revenue was up 7.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.86 EPS.

Docusign Price Performance

NASDAQ DOCU traded up $0.72 on Tuesday, hitting $47.54. 7,859,945 shares of the company were exchanged, compared to its average volume of 5,164,105. Docusign has a twelve month low of $40.16 and a twelve month high of $94.67. The company’s 50 day moving average price is $51.11 and its 200-day moving average price is $64.46. The firm has a market capitalization of $9.52 billion, a P/E ratio of 32.97, a price-to-earnings-growth ratio of 2.04 and a beta of 1.03.

Insider Buying and Selling

In other news, insider James P. Shaughnessy sold 12,000 shares of the business’s stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $67.03, for a total transaction of $804,360.00. Following the transaction, the insider directly owned 54,550 shares in the company, valued at $3,656,486.50. The trade was a 18.03% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CRO Paula Hansen sold 6,000 shares of the stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $67.05, for a total value of $402,300.00. Following the completion of the transaction, the executive owned 68,970 shares in the company, valued at $4,624,438.50. This represents a 8.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 74,810 shares of company stock valued at $5,115,951. 1.66% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. State Street Corp lifted its stake in Docusign by 0.9% in the fourth quarter. State Street Corp now owns 8,193,805 shares of the company’s stock valued at $560,456,000 after buying an additional 77,008 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Docusign by 8.1% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,343,613 shares of the company’s stock valued at $228,703,000 after buying an additional 251,639 shares during the period. Invesco Ltd. increased its holdings in Docusign by 4.5% during the 3rd quarter. Invesco Ltd. now owns 2,690,121 shares of the company’s stock worth $193,931,000 after purchasing an additional 116,047 shares in the last quarter. Northern Trust Corp raised its position in Docusign by 2.0% in the 3rd quarter. Northern Trust Corp now owns 1,994,004 shares of the company’s stock valued at $143,748,000 after buying an additional 39,140 shares during the last quarter. Finally, Wellington Management Group LLP raised its holdings in shares of Docusign by 0.5% in the third quarter. Wellington Management Group LLP now owns 1,860,347 shares of the company’s stock valued at $134,112,000 after purchasing an additional 9,861 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

Trending Headlines about Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q4 earnings and revenue beat consensus (EPS $1.01 vs. $0.95 estimate), showing upside to recent expectations — this is the primary near‑term catalyst supporting the stock. DocuSign (DOCU) Beats Q4 Earnings and Revenue Estimates
• Positive Sentiment: Company raised its share buyback authorization by $2.0 billion — a direct capital‑allocation move that supports EPS and can buoy the stock. Docusign Announces Fourth Quarter and Fiscal Year 2026 Financial Results; Announces $2.0 Billion Increase to Share Repurchase Program
• Positive Sentiment: Board addition of an AI‑focused independent director and ongoing AI product integrations are being viewed as strategic positives that could drive future subscription expansion beyond e‑signatures. The Bull Case For DocuSign (DOCU) Could Change Following New AI-Focused Director Appointment – Learn Why
• Neutral Sentiment: Analysts and previews focused on key Q4 metrics and guidance comparisons; these items will matter for next‑quarter sentiment but are read as routine post‑earnings analysis. DocuSign (DOCU) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
• Neutral Sentiment: Marketwide drivers (Fed/FOMC meeting, macro data, big‑tech events) are creating broader volatility that could amplify DOCU moves short‑term. Markets Wait for Fed’s FOMC Meeting
• Negative Sentiment: Bearish commentary warns DOCU remains vulnerable after a steep multi‑month pullback; some analysts flag valuation and downside risk if execution or guidance disappoints. DocuSign stock price at risk of a steep crash after earnings on March 17

Analysts Set New Price Targets

DOCU has been the subject of a number of recent research reports. Needham & Company LLC reiterated a “hold” rating on shares of Docusign in a research report on Tuesday, March 10th. Robert W. Baird reduced their price target on shares of Docusign from $90.00 to $75.00 and set a “neutral” rating on the stock in a research report on Friday, December 5th. UBS Group lowered their target price on Docusign from $85.00 to $75.00 and set a “neutral” rating for the company in a research note on Friday, December 5th. Weiss Ratings reissued a “hold (c)” rating on shares of Docusign in a research report on Wednesday, January 21st. Finally, JPMorgan Chase & Co. decreased their price target on shares of Docusign from $80.00 to $78.00 and set a “neutral” rating for the company in a research report on Friday, December 5th. Five equities research analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $78.80.

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.